Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.1897
+0.0100 (5.56%)
Sep 10, 2025, 3:19 PM - Market open
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $9.55 million as of September 10, 2025. Its market cap has increased by 98.15% in one year.
Market Cap
9.55M
Enterprise Value
2.14M
1-Year Change
98.15%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since October 9, 2017, Processa Pharmaceuticals's market cap has decreased from $1.04B to $9.55M, a decrease of -99.08%. That is a compound annual growth rate of -44.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 9.05M | 213.36% |
| Dec 31, 2024 | 2.89M | -64.97% |
| Dec 29, 2023 | 8.24M | -53.15% |
| Dec 30, 2022 | 17.59M | -77.16% |
| Dec 31, 2021 | 77.01M | 10.52% |
| Dec 31, 2020 | 69.68M | -29.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |